Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon Sep 08, 2020 1:23pm
137 Views
Post# 31520804

Be careful

Be carefulMonth ago Liminal announced the acquisition of scientifics assets from the biotech Fairhaven.
In fact this business was owned by ken Galbraith and Garry Bridger, CEO and board member of Liminal. Over and above the money they personaly earned the purpose of the transaction was a $3 millionsd cross financing.

It's fun to see what they are willing to do for some bucks...

This long awaiting filing is-it the conclusion of a very well prepared documentation or an other emergency solution to wake up the market and trying to find some money.

Today they are out of cash. They only have SALP credit margin (if still available) to continue running.

Should we trust them? Time will tell. 
<< Previous
Bullboard Posts
Next >>